Insider: Bredt David Chief Scientific Officer - Rapport Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 387,075 | 0 | 387,075 |
| Value | $12,997,978.50 | $0.00 | $12,997,978.50 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/17/2026 | DDS | 2,200 | Direct | COM | $29.59 | $65,107.68 | 387,075 |
| 02/17/2026 | DDS | 900 | Direct | COM | $28.02 | $25,218.99 | 394,675 |
| 02/17/2026 | DDS | 5,400 | Direct | COM | $28.95 | $156,328.38 | 389,275 |
| 01/15/2026 | DDS | 8,300 | Direct | COM | $26.83 | $222,651.65 | 395,775 |
| 01/15/2026 | DDS | 200 | Direct | COM | $27.40 | $5,480.00 | 395,575 |
| 12/31/2025 | DDS | 6,567 | Direct | COM | $30.05 | $197,337.69 | 404,075 |
| 12/15/2025 | DDS | 796 | Direct | COM | $30.68 | $24,419.05 | 392,642 |
| 12/15/2025 | DDS | 7,704 | Direct | COM | $29.95 | $230,710.92 | 393,438 |
| 11/17/2025 | DDS | 3,156 | Direct | COM | $24.84 | $78,394.72 | 406,486 |
| 11/17/2025 | DDS | 5,344 | Direct | COM | $25.39 | $135,695.92 | 401,142 |
| 10/15/2025 | DDS | 7,418 | Direct | COM | $25.73 | $190,886.65 | 410,724 |
| 10/15/2025 | DDS | 1,082 | Direct | COM | $26.16 | $28,309.56 | 409,642 |
| 09/15/2025 | DDS | 3,402 | Direct | COM | $24.66 | $83,887.54 | 418,142 |
| 09/15/2025 | DDS | 5,098 | Direct | COM | $23.88 | $121,761.14 | 421,544 |
| 08/15/2025 | DDS | 8,300 | Direct | COM | $14.98 | $124,308.27 | 426,842 |
| 08/15/2025 | DDS | 200 | Direct | COM | $15.79 | $3,158.00 | 426,642 |
| 07/15/2025 | DDS | 8,500 | Direct | COM | $14.00 | $118,961.75 | 435,142 |
| 06/16/2025 | DDS | 8,500 | Direct | COM | $11.00 | $93,522.10 | 443,642 |
| 05/15/2025 | DDS | 8,500 | Direct | COM | $9.56 | $81,261.70 | 452,142 |
| 04/15/2025 | DDS | 8,500 | Direct | COM | $9.57 | $81,310.15 | 460,642 |
| 03/14/2025 | DDS | 8,500 | Direct | COM | $10.85 | $92,205.45 | 469,142 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research